Please login to the form below

Not currently logged in
Email:
Password:

allogenic cell therapies

This page shows the latest allogenic cell therapies news and features for those working in and with pharma, biotech and healthcare.

Roche bets on T-cell therapies with Adaptimmune deal

Roche bets on T-cell therapies with Adaptimmune deal

Unlike other leaders in next-generation cell therapies, the partners will use allogenic T-cells rather than immune cells taken from and returned to an individual’s body as with many ... their cancer; a significant step towards our goal of making cell

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Pharma deals during February 2014 Pharma deals during February 2014

    Cellectis, an expert in allogenic CAR T-cell therapies, signed a strategic collaboration with Servier to cover Cellectic's lead product UCART-19 targeted at leukaemia and lymphomas. ... The FDA Complete Response Letter relating to an advanced renal cell

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Langland

Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....